1,25-Dihydroxyvitamin D3 attenuates platelet aggregation potentiated by SARS-CoV-2 spike protein via inhibiting integrin αIIbβ3 outside-in signaling
View abstract on PubMed
Summary
This summary is machine-generated.Vitamin D (1,25(OH)2D3) reduces platelet hyperreactivity caused by the SARS-CoV-2 spike protein. This effect is mediated by downregulating integrin signaling, offering potential therapeutic insights for COVID-19-related clotting.
Area Of Science
- Cardiovascular Biology
- Immunology
- Endocrinology
Background
- Platelet hyperreactivity is implicated in COVID-19 pathogenesis, leading to hypercoagulability and thrombosis.
- Vitamin D deficiency correlates with increased COVID-19 severity.
- Vitamin D supplementation is a common, safe dietary intervention.
Purpose Of The Study
- To investigate the direct effects of 1,25(OH)2D3 on platelet hyperreactivity induced by SARS-CoV-2 spike protein.
- To elucidate the underlying molecular mechanisms of 1,25(OH)2D3's action on platelets.
Main Methods
- In vitro platelet functional studies.
- Western blot analysis to assess signaling pathways.
- Utilized SARS-CoV-2 spike protein to induce platelet responses.
- Employed Src family kinase inhibitor (PP2) for mechanistic insights.
Main Results
- 1,25(OH)2D3 attenuated platelet aggregation and Src-mediated signaling.
- 1,25(OH)2D3 inhibited spike protein-potentiated platelet aggregation in vitro.
- 1,25(OH)2D3 downregulated spike protein-induced integrin αIIbβ3 outside-in signaling, including platelet spreading and phosphorylation of β3, c-Src, and Syk.
- Combined inhibition with PP2 and 1,25(OH)2D3 showed no additive effects, suggesting a shared pathway.
Conclusions
- 1,25(OH)2D3 mitigates platelet hyperreactivity induced by the SARS-CoV-2 spike protein.
- The mechanism involves the downregulation of integrin αIIbβ3 outside-in signaling.
- These findings suggest a potential role for Vitamin D in managing COVID-19-associated thrombotic complications.
Related Concept Videos
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...

